These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 17970057)

  • 1. Experimental models for therapeutic studies of transitional cell carcinoma.
    Gabriel U; Bolenz C; Michel MS
    Anticancer Res; 2007; 27(5A):3163-71. PubMed ID: 17970057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mouse orthotopic models for bladder cancer research.
    Chan E; Patel A; Heston W; Larchian W
    BJU Int; 2009 Nov; 104(9):1286-91. PubMed ID: 19388981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characterization of a novel transplantable orthotopic nude mouse model with xenografted human bladder transitional cell tumor (BIU-87)].
    Li C; Yan RP; Yuan GH; Feng YG; Wang JS; Gao X; Huang YS; Zhou JB; Xie SS
    Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):733-6. PubMed ID: 17366782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model.
    Xiao Z; McCallum TJ; Brown KM; Miller GG; Halls SB; Parney I; Moore RB
    Br J Cancer; 1999 Oct; 81(4):638-46. PubMed ID: 10574249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmacytoid transitional cell carcinoma of urinary bladder: a clinicopathologic study of 9 cases.
    Ro JY; Shen SS; Lee HI; Hong EK; Lee YH; Cho NH; Jung SJ; Choi YJ; Ayala AG
    Am J Surg Pathol; 2008 May; 32(5):752-7. PubMed ID: 18379419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine invasive transitional cell carcinoma cell lines: in vitro tools to complement a relevant animal model of invasive urinary bladder cancer.
    Dhawan D; Ramos-Vara JA; Stewart JC; Zheng R; Knapp DW
    Urol Oncol; 2009; 27(3):284-92. PubMed ID: 18562222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.
    Olbert PJ; Schrader AJ; Simon C; Dalpke A; Barth P; Hofmann R; Hegele A
    Anticancer Res; 2009 Jun; 29(6):2067-76. PubMed ID: 19528466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bladder cancer following upper tract urothelial carcinoma.
    Kauffman EC; Raman JD
    Expert Rev Anticancer Ther; 2008 Jan; 8(1):75-85. PubMed ID: 18095885
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral profiling of human transitional cell carcinoma ex vivo.
    Estrada CR; Salanga M; Bielenberg DR; Harrell WB; Zurakowski D; Zhu X; Palmer MR; Freeman MR; Adam RM
    Cancer Res; 2006 Mar; 66(6):3078-86. PubMed ID: 16540657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic assessment and clinical significance of prostatic involvement by transitional cell carcinoma and prostate cancer.
    Lerner SP; Shen S
    Urol Oncol; 2008; 26(5):481-5. PubMed ID: 18774459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transitional cell carcinoma of the urinary bladder: a clinicopathological study.
    Matalka I; Bani-Hani K; Shotar A; Bani Hani O; Bani-Hani I
    Singapore Med J; 2008 Oct; 49(10):790-4. PubMed ID: 18946612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bladder cancer: modeling and translation.
    Rosenberg JE; Hahn WC
    Genes Dev; 2009 Mar; 23(6):655-9. PubMed ID: 19299556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The application of epigenetic modifiers on the treatment of prostate and bladder cancer.
    Zhang Z; Karam J; Frenkel E; Sagalowsky A; Hsieh JT
    Urol Oncol; 2006; 24(2):152-60. PubMed ID: 16520279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostatic transitional cell carcinoma: pathologic features and clinical management.
    Shen SS; Lerner SP
    Expert Rev Anticancer Ther; 2007 Aug; 7(8):1155-62. PubMed ID: 18028024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modeling human bladder cancer.
    Ringuette-Goulet C; Bolduc S; Pouliot F
    World J Urol; 2018 Nov; 36(11):1759-1766. PubMed ID: 29948049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nested variant of transitional cell carcinoma with osseous metaplasia of the urinary bladder: a case report and review of published reports.
    Neşe N; Kandiloğlu AR; Atesçi YZ
    Int J Urol; 2007 Apr; 14(4):365-7. PubMed ID: 17470174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urine concentration of nuclear matrix protein 22 for diagnosis of transitional cell carcinoma of bladder.
    Jamshidian H; Kor K; Djalali M
    Urol J; 2008; 5(4):243-7. PubMed ID: 19101898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The optimal management of T1G3 bladder cancer.
    Emiliozzi P; Pansadoro A; Pansadoro V
    BJU Int; 2008 Nov; 102(9 Pt B):1265-73. PubMed ID: 19035891
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcomes of surgical treatment for upper urinary tract transitional cell carcinoma: comparison of retroperitoneoscopic and open nephroureterectomy.
    Taweemonkongsap T; Nualyong C; Amornvesukit T; Leewansangtong S; Srinualnad S; Chaiyaprasithi B; Sujijantararat P; Tantiwong A; Soontrapa S
    World J Surg Oncol; 2008 Jan; 6():3. PubMed ID: 18194580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of combined therapy in carcinoma of the bladder.
    Kagan AR; Gilbert HA
    Cancer Clin Trials; 1978; 1(4):305-6. PubMed ID: 391430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.